Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
Thyrotoxicosis with toxic multinodular goitre	HP_0011785
antibody secreting cell	CL_0000946	[A lymphocyte of B lineage that is devoted to secreting large amounts of immunoglobulin.]
lymphocyte of B lineage	CL_0000945	[A lymphocyte of B lineage is a lymphocyte that expresses CD19 on the cell surface. An additional defining characteristic is the commitment to express an immunoglobulin complex.]
pro-B cell	CL_0000826	[A progenitor cell of the B cell lineage, with some lineage specific activity such as early stages of recombination of B cell receptor genes, but not yet fully committed to the B cell lineage until the expression of PAX5 occurs.]
Impaired epinephrine-induced platelet aggregation	HP_0008148	[Abnormal response to epinephrine as manifested by reduced or lacking aggregation of platelets upon addition of epinephrine.]
Flattening of the talar dome	HP_0008144
Delayed calcaneal ossification	HP_0008142	[Delayed maturation and calcification of the calcaneus.]
Delayed tarsal ossification	HP_0008103	[Delayed maturation and calcification of any of the tarsal bones, seven bones of the foot comprising the calcaneus, talus, cuboid, navicular, and the cuneiform bones.]
Prolonged prothrombin time	HP_0008151	[Increased time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.]
Inactivating thyroid-stimulating hormone receptor defect	HP_0011791	[Loss-of-function thyroid-stimulating hormone receptor (TSHR) defect.]
Elevated serum transaminases during infections	HP_0008150	[Elevations of the levels of SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) that occur during infections.]
Papillary renal cell carcinoma type 1	HP_0011797	[A type of papillary renal cell carcinoma that is characterized by small cuboidal cells covering thin papillae with a single line of uniform nuclei and small nucleoli.]
Papillary renal cell carcinoma	HP_0006766	[The presence of renal cell carcinoma in the renal papilla.]
Renal oncocytoma	HP_0011798	[A renal tumor originating from an oncocyte, which is an epithelial cell characterized by an excessive amount of mitochondria, resulting in an abundant acidophilic, granular cytoplasm.]
Intralobar nephroblastomatosis	HP_0011795	[Presence of persistent islands of renal blastema in the postnatal kidney, anywhere within a renal lobe (a portion of a kidney consisting of a renal pyramid and the renal cortex above it).]
Nephroblastomatosis	HP_0008643	[Presence of persistent islands of renal blastema in the postnatal kidney. Nephroblastomatosis represents a complex abnormality of nephrogenesis and has been defined as the persistence of metanephricblastema into infancy and childhood.]
Perilobar nephroblastomatosis	HP_0011796	[Abnormally persistent foci of embryonal immature blastema located in the superficial cortical region (perilobar).]
Activating thyroid-stimulating hormone receptor defect	HP_0011790	[Gain-of-function thyroid-stimulating hormone receptor (TSHR) defect.]
Hyperapobetalipoproteinemia	HP_0008158	[Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an increased LDL apolipoprotein B (apoB) protein.]
Periodic hypokalemic paresis	HP_0008153	[Episodes of muscle weakness associated with reduced levels of potassium in the blood.]